Novartis sacrifices its top attorney in an attempt to quell clamor over $1.2M in Cohen payments — while ex-CEO Jimenez struggles to explain
BioRegnum — The view from John Carroll
Faced with a growing crisis over its $1.2 million in payments to President Donald Trump’s personal attorney Michael Cohen, Novartis announced early Wednesday that the company’s top lawyer has abruptly resigned in hopes of bringing the whole tawdry affair to an end.
“Although the contract (with Cohen) was legally in order, it was an error,” said Felix Ehrat, group general counsel of Novartis, in a statement. “As a co-signatory with our former CEO, I take personal responsibility to bring the public debate on this matter to an end.”
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.
